S&P 500   4,293.93
DOW   33,833.61
QQQ   353.15
High Dividend REITs: Are They an Ideal Way to Diversify?
The single greatest medical breakthrough of all time? (Ad)
Stock market today: Asian shares mostly rise, lifted by bull market on Wall Street
2 Dow Stocks Trading Less Than 10x Earnings are Blue Chip Values
The single greatest medical breakthrough of all time? (Ad)
Boost for homebuyers: Average long-term US mortgage rate eases from 7-month high to 6.71% this week
6 Best Online and Direct Marketing Retail Stocks to Invest in
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Homebuilding Stocks Defying Cooling Housing Market: Time to Sell?
The S&P 500 is in a bull market. Here's what that means and how long the bull might run
S&P 500   4,293.93
DOW   33,833.61
QQQ   353.15
High Dividend REITs: Are They an Ideal Way to Diversify?
The single greatest medical breakthrough of all time? (Ad)
Stock market today: Asian shares mostly rise, lifted by bull market on Wall Street
2 Dow Stocks Trading Less Than 10x Earnings are Blue Chip Values
The single greatest medical breakthrough of all time? (Ad)
Boost for homebuyers: Average long-term US mortgage rate eases from 7-month high to 6.71% this week
6 Best Online and Direct Marketing Retail Stocks to Invest in
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Homebuilding Stocks Defying Cooling Housing Market: Time to Sell?
The S&P 500 is in a bull market. Here's what that means and how long the bull might run
S&P 500   4,293.93
DOW   33,833.61
QQQ   353.15
High Dividend REITs: Are They an Ideal Way to Diversify?
The single greatest medical breakthrough of all time? (Ad)
Stock market today: Asian shares mostly rise, lifted by bull market on Wall Street
2 Dow Stocks Trading Less Than 10x Earnings are Blue Chip Values
The single greatest medical breakthrough of all time? (Ad)
Boost for homebuyers: Average long-term US mortgage rate eases from 7-month high to 6.71% this week
6 Best Online and Direct Marketing Retail Stocks to Invest in
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Homebuilding Stocks Defying Cooling Housing Market: Time to Sell?
The S&P 500 is in a bull market. Here's what that means and how long the bull might run
S&P 500   4,293.93
DOW   33,833.61
QQQ   353.15
High Dividend REITs: Are They an Ideal Way to Diversify?
The single greatest medical breakthrough of all time? (Ad)
Stock market today: Asian shares mostly rise, lifted by bull market on Wall Street
2 Dow Stocks Trading Less Than 10x Earnings are Blue Chip Values
The single greatest medical breakthrough of all time? (Ad)
Boost for homebuyers: Average long-term US mortgage rate eases from 7-month high to 6.71% this week
6 Best Online and Direct Marketing Retail Stocks to Invest in
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Homebuilding Stocks Defying Cooling Housing Market: Time to Sell?
The S&P 500 is in a bull market. Here's what that means and how long the bull might run
NASDAQ:INGN

Inogen (INGN) Stock Forecast, Price & News

$10.68
-0.48 (-4.30%)
(As of 06/8/2023 ET)
Compare
Today's Range
$10.63
$11.13
50-Day Range
$10.01
$13.86
52-Week Range
$9.88
$32.01
Volume
306,095 shs
Average Volume
270,370 shs
Market Capitalization
$246.93 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$24.00

Inogen MarketRank™ Forecast

Analyst Rating
Hold
2.33 Rating Score
Upside/​Downside
124.7% Upside
$24.00 Price Target
Short Interest
Bearish
5.15% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-1.12
Upright™ Environmental Score
News Sentiment
0.91mentions of Inogen in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($2.16) to ($1.42) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.13 out of 5 stars

Medical Sector

388th out of 986 stocks

Surgical Appliances & Supplies Industry

9th out of 18 stocks


INGN stock logo

About Inogen (NASDAQ:INGN) Stock

Inogen, Inc. is a medical technology company, which engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its products include Inogen One G4 system, Inogen One G3 system, Inogen One G5 system, Inogen TAV, and Inogen at Home. The company was founded by Alison Perry, Alison K. Bauerlein, Brenton Taylor, and Byron Myers on November 27, 2001 and is headquartered in Goleta, CA.

Receive INGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inogen and its competitors with MarketBeat's FREE daily newsletter.

INGN Stock News Headlines

Will the Current Downturn Affect Inogen (INGN)?
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
Inogen (NASDAQ:INGN) Downgraded by StockNews.com to Sell
Inogen (NASDAQ:INGN) Upgraded to "Hold" at StockNews.com
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
Inogen (INGN) Scheduled to Post Earnings on Thursday
Inogen (NASDAQ:INGN) Cut to "Sell" at StockNews.com
Inogen (NASDAQ:INGN) Rating Lowered to Sell at StockNews.com
A Look At The Fair Value Of Inogen, Inc. (NASDAQ:INGN)
Inogen (NASDAQ:INGN) Raised to "Hold" at StockNews.com
Inogen (NASDAQ:INGN) Stock Rating Lowered by StockNews.com
See More Headlines

INGN Price History

INGN Company Calendar

Last Earnings
5/04/2023
Today
6/08/2023
Next Earnings (Estimated)
8/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:INGN
Fax
N/A
Employees
1,026
Year Founded
2001

Price Target and Rating

Average Stock Price Forecast
$24.00
High Stock Price Forecast
$26.00
Low Stock Price Forecast
$22.00
Forecasted Upside/Downside
+124.7%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

Net Income
$-83,770,000.00
Pretax Margin
-24.24%

Debt

Sales & Book Value

Annual Sales
$369.02 million
Book Value
$12.98 per share

Miscellaneous

Free Float
22,973,000
Market Cap
$246.93 million
Optionable
Optionable
Beta
1.02

Social Links


Key Executives

  • Nabil Shabshab
    President, Chief Executive Officer & Director
  • Kristin A. Caltrider
    Chief Financial Officer, Treasurer & EVP
  • Stanislav Glezer
    Chief Technology Officer & Executive VP
  • George J. Parr
    Chief Commercial Officer & Executive VP
  • Jason Somer
    Secretary, Executive VP & General Counsel













INGN Stock - Frequently Asked Questions

Should I buy or sell Inogen stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Inogen in the last year. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" INGN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in INGN, but not buy additional shares or sell existing shares.
View INGN analyst ratings
or view top-rated stocks.

What is Inogen's stock price forecast for 2023?

3 brokers have issued twelve-month price objectives for Inogen's stock. Their INGN share price forecasts range from $22.00 to $26.00. On average, they expect the company's share price to reach $24.00 in the next year. This suggests a possible upside of 124.7% from the stock's current price.
View analysts price targets for INGN
or view top-rated stocks among Wall Street analysts.

How have INGN shares performed in 2023?

Inogen's stock was trading at $19.71 on January 1st, 2023. Since then, INGN shares have decreased by 45.8% and is now trading at $10.68.
View the best growth stocks for 2023 here
.

When is Inogen's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our INGN earnings forecast
.

How were Inogen's earnings last quarter?

Inogen, Inc. (NASDAQ:INGN) posted its earnings results on Thursday, May, 4th. The medical technology company reported ($0.63) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.77) by $0.14. The medical technology company had revenue of $72.16 million for the quarter, compared to analyst estimates of $74.68 million. Inogen had a negative trailing twelve-month return on equity of 11.06% and a negative net margin of 24.36%. Inogen's quarterly revenue was down 10.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted ($0.38) earnings per share.

What is Scott Wilkinson's approval rating as Inogen's CEO?

70 employees have rated Inogen Chief Executive Officer Scott Wilkinson on Glassdoor.com. Scott Wilkinson has an approval rating of 46% among the company's employees. This puts Scott Wilkinson in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Inogen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Inogen investors own include Puma Biotechnology (PBYI), BioMarin Pharmaceutical (BMRN), Incyte (INCY), (MDVN) (MDVN), NVIDIA (NVDA), Alibaba Group (BABA), Advanced Micro Devices (AMD), First Solar (FSLR), Intel (INTC) and Netflix (NFLX).

What is Inogen's stock symbol?

Inogen trades on the NASDAQ under the ticker symbol "INGN."

Who are Inogen's major shareholders?

Inogen's stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (17.20%), Brown Capital Management LLC (9.55%), Fred Alger Management LLC (4.86%), State Street Corp (4.65%), Dimensional Fund Advisors LP (3.72%) and Geode Capital Management LLC (1.95%). Insiders that own company stock include Alison Bauerlein, Brenton Taylor, Byron Myers, Holdings A/S Novo, Ray Benjamin M Anderson and Raymond Huggenberger.
View institutional ownership trends
.

How do I buy shares of Inogen?

Shares of INGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Inogen's stock price today?

One share of INGN stock can currently be purchased for approximately $10.68.

How much money does Inogen make?

Inogen (NASDAQ:INGN) has a market capitalization of $246.93 million and generates $369.02 million in revenue each year. The medical technology company earns $-83,770,000.00 in net income (profit) each year or ($3.92) on an earnings per share basis.

How many employees does Inogen have?

The company employs 1,026 workers across the globe.

How can I contact Inogen?

Inogen's mailing address is 326 BOLLAY DRIVE, GOLETA CA, 93117. The official website for the company is www.inogen.com. The medical technology company can be reached via phone at (805) 562-0500 or via email at mpigeon@inogen.net.

This page (NASDAQ:INGN) was last updated on 6/9/2023 by MarketBeat.com Staff

My Account -